When was Q-Interline founded?

Q-Interline was founded in 1996.

Where is Q-Interline located?

Q-Interline is headquartered in Tollose, Denmark. It is registered at 4 B RUE DE LA NOE 35170 BRUZ.

How many employees does Q-Interline have?

As of Jul 01, 2024, the latest employee count at Q-Interline is 30.

Is Q-Interline a funded company?

Q-Interline is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round.

When was the latest funding round of Q-Interline?

Q-Interline's latest funding was a $***** Grant (prize money) round on Oct 01, 2017, with participation from 1 investor.

Where does Q-Interline rank among its competitors?

Q-Interline ranks 241st amongst 4144 active competitors, of which 36 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was EBOS Group, which secured $124M in Apr, 2025.

Who are the top competitors of Q-Interline?

Q-Interline's top competitors include AmerisourceBergen, Entero Healthcare and EBOS Group. Among them, EBOS Group secured the most recent funding round in April, 2025.

Q-Interline - 2026 Company Profile, Funding & Competitors

Company Details

Website: q-interline.com
Email ID: *****@q-interline.com
Phone Number: +45 **********
Registered Address: 4 B RUE DE LA NOE 35170 BRUZ

Key Metrics

Founded Year

1996

Location

Tollose, Denmark

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Oct 01, 2017, $*****

Investors

EIC Fund & 2 more

Ranked

241^st among 4144 active competitors

Employee Count

30 as on Jul 01, 2024

Similar Companies

Karat & 96 more

View Q-Interline's full profile

Q-Interline is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Q-Interline SARL CIN: 911513323 , France, Active	Sep 09, 2022	-	-	-
Q-INTERLINE A/S CIN: 19614409 , Denmark, Active		-	31 (As on Mar 31, 2024)

Q-Interline has raised funding over 3 rounds. Its latest funding round was a Grant (prize money) round on Oct 01, 2017 for $*****. 1 investor participated in its latest round. Q-Interline has 3 institutional investors.

Here is the list of recent funding rounds of Q-Interline:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 01, 2017	4613019	Grant (prize money)	7228167	8660418	3692557	9922676
2016	3081	Grant (prize money)	6511	6008	8599	EIC Fund

Access funding benchmarks and valuations. Sign up today!

View details of Q-Interline's funding rounds and investors

Q-Interline's employee count trend

Q-Interline has 30 employees as of Jul 24. Here is Q-Interline's employee count trend over the years:

Uncover Q-Interline's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Q-Interline include AmerisourceBergen, Entero Healthcare and EBOS Group. Here is the list of Top 10 competitors of Q-Interline, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AmerisourceBergen 1985, Chesterbrook (United States), Public	Drug Corporation	-	nextGENE Capital, Walgreens Boots Alliance ... & 4 others	68/100
2nd	Entero Healthcare 2018, Mumbai (India), Public	Operator of an integrated healthcare products distribution platform	$59.7M	Orbimed, Millennium Medicare & 38 others	66/100
3rd	EBOS Group 1922, Docklands (Australia), Public	Wholesaler & distributor of healthcare, medical, and pharmaceutical products	-	-	59/100
4th	Keimed 2000, Hyderabad (India), Series B	Pharmaceutical distributor of temperature-sensitive medicines	$16.6M	Mitsui, Apollo Hospitals & 4 others	59/100
5th	Cencora 2001, Conshohocken (United States), Public	Provider of clinical trial logistics and other biopharma outsourcing services	-	-	57/100
6th	CHEPLAPHARM 1998, Mesekenhagen (Germany), Late Stage	Pharmaceutical company that specializes in the development, marketing, and distribution of branded pharmaceutical products	$547M	GIC, Atlantic Park & 4 others	56/100
7th	Target Healthcare 2012, East Kilbride (United Kingdom), Series B	Distributor of pharmaceutical products	$26.1M	Santander	51/100
8th	Dizal Pharma 2017, Pudong (China), Series A	Limited information available	$100M	Lilly Asia Ventures, HongShan & 3 others	49/100
9th	Karat 2000, Chino (United States), Public	Beverage and food service disposable products processing company	-	-	49/100
10th	AvKARE 2007, Pulaski (United States), Acquired	Distributor of pharmaceuticals and infection control products	-	-	49/100
241st	Q-Interline 1996, Tollose (Denmark), Funding Raised	Manufacturer of analyzers and spectrometers	-	EIC Fund, Europa & 1 others	28/100